The concern about hypoglycemia is more acute during the first several weeks of combining both compounds, before the body equilibrates to the combined glucose-lowering load
We should like to stress that B12 was selected for these purely epidemiological considerations and with no malice aforethought
Saxenda is approved for weight management in adults and adolescents with obesity (BMI 30) or overweight (BMI 27) with conditions like high cholesterol, high blood pressure, or type 2 diabetes
By binding to growth hormone-releasing hormone (GHRH) receptors, CJC-1295 promotes a sustained increase in growth hormone and IGF-1 levels, which are essential for cell regeneration, fat metabolism, and muscle growth
The ATTAIN program for obesity includes ATTAIN-1 (NCT05869903, completed), ATTAIN-2 (NCT05872620, completed), ATTAIN-3 (completed), and ATTAIN-MAINTAIN (completed)
R.PotterJ